Clinical Trial Update: A Study to Determine the Efficacy and Safety of Tividenofusp Alfa (DNL310) vs Idursulfase in Pediatric and Young Adult Participants With Neuronopathic (nMPS II) or Non-Neuronopathic Mucopolysaccharidosis Type II (nnMPS II) [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for Tividenofusp Alfa (DNL310) vs Idursulfase in pediatric and young adult patients with Mucopolysaccharidosis type II, including neuronop…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mucopolysaccharidosis Type Ii

Drugs mentioned

• Idursulfase (idursulfase)
• Tividenofusp alfa (tividenofusp alfa)

Snippet

Sponsor: Denali Therapeutics Inc. | Conditions: Mucopolysaccharidosis II | Phase 2, Phase 3 | Status: RECRUITING